
Loading, please wait...

Loading, please wait...

Managing maxillary hypoplasia in cleft patients requires precision and strategic timing. A recent retrospective study analyzed the effectiveness of the Le Fort I osteotomy across different age groups. Specifically, researchers compared 28 growing patients with 59 non-growing individuals to assess craniofacial morphology changes. Surgeons often debate whether early intervention provides better stability than waiting for skeletal maturity. Consequently, this study offers crucial insights into that decision-making process for multidisciplinary cleft teams.
The data revealed that growing patients presented with more severe preoperative conditions. Therefore, this group required significantly larger horizontal advancements of Point A, averaging 6.4 mm compared to 3.2 mm in older patients. Despite these initial differences, both groups achieved similar postoperative cephalometric alignments. Furthermore, the use of miniplates or patient-specific implants provided stable fixation during the procedure. However, practitioners must note that early surgery in growing patients often functions as a two-stage approach. Most of these individuals eventually require a second correction once they reach skeletal maturity.
Timing remains a critical factor for long-term surgical success. Additionally, the study suggests that severe maxillary hypoplasia does not preclude successful early correction. Therefore, surgeons can achieve significant improvements in facial morphology even in younger cohorts. Nevertheless, practitioners must counsel families regarding the high probability of future revisions. This balanced approach ensures that patients benefit from improved aesthetics and function during their developmental years while preparing for final adulthood alignment. Moreover, customized implants continue to improve the predictability of these complex advancements.
Yes, the procedure is safe and effective for correcting severe maxillary hypoplasia in growing patients. However, it is often viewed as a temporary correction because further growth may necessitate a second surgery in adulthood.
Younger patients in the Pre-Growth-Completion group often present with more severe skeletal discrepancies. Consequently, they require larger horizontal movements to achieve normal facial proportions compared to patients who have finished growing.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Retrospective study compares Le Fort I osteotomy in growing and non-growing cleft patients, noting that younger patients require more maxillary advancement....
7 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today